Human Genome Epidemiology Literature Finder
Records 1 - 11 (of 11 Records) |
Query Trace: Pain and EGFR[original query] |
---|
Phase III study of afatinib or cisplatin plus pemetrexed in patients with metastatic lung adenocarcinoma with EGFR mutations. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013 Sep 31 (27): 3327-34. Sequist Lecia V, Yang James Chih-Hsin, Yamamoto Nobuyuki, O'Byrne Kenneth, Hirsh Vera, Mok Tony, Geater Sarayut Lucien, Orlov Sergey, Tsai Chun-Ming, Boyer Michael, Su Wu-Chou, Bennouna Jaafar, Kato Terufumi, Gorbunova Vera, Lee Ki Hyeong, Shah Riyaz, Massey Dan, Zazulina Victoria, Shahidi Mehdi, Schuler Mart |
Clinical Features and Gene Mutations of Lung Cancer Patients 30 Years of Age or Younger. PloS one 2015 10 (9): e0136659. Wang Yuehong, Chen Junjun, Ding Wei, Yan Bing, Gao Qiqi, Zhou Jianyi |
A phase I study of foretinib plus erlotinib in patients with previously treated advanced non-small cell lung cancer: Canadian cancer trials group IND.196. Oncotarget 2017 Sep 8 (41): 69651-69662. Leighl Natasha B, Tsao Ming-Sound, Liu Geoffrey, Tu Dongsheng, Ho Cheryl, Shepherd Frances A, Murray Nevin, Goffin John R, Nicholas Garth, Sakashita Shingo, Chen Zhuo, Kim Lucia, Powers Jean, Seymour Lesley, Goss Glenwood, Bradbury Penelope |
Nonsmall cell lung cancer with rare exon 7 p.A289V mutation in the EGFR gene responds to Icotinib treatment: A case report. Medicine 2018 12 97 (51): e13809. Dai Limeng, Su Xuejiao, Lu Lin, Lv Dongl |
Multicenter phase II study on cisplatin, pemetrexed, and bevacizumab followed by maintenance with pemetrexed and bevacizumab for patients with advanced or recurrent nonsquamous non-small cell lung cancer: MAP study. BMC cancer 2018 Dec 18 (1): 1231. Tsutani Yasuhiro, Miyata Yoshihiro, Masuda Takeshi, Fujitaka Kazunori, Doi Mihoko, Awaya Yoshikazu, Kuyama Shoichi, Kitaguchi Soichi, Ueda Kazuhiro, Hattori Noboru, Okada Morihi |
Bone, muscle, and metabolic parameters predict survival in patients with synchronous bone metastases from lung cancers. Bone 2018 1 108 202-209. Chambard Lauriane, Girard Nicolas, Ollier Edouard, Rousseau Jean-Charles, Duboeuf François, Carlier Marie-Christine, Brevet Marie, Szulc Pawel, Pialat Jean-Baptiste, Wegrzyn Julien, Clezardin Philippe, Confavreux Cyrille |
Intracavitary chemotherapy with epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) is not superior to TKI monotherapy in controlling malignant pleural effusion recurrence in EGFR-mutated lung cancer patients. Journal of thoracic disease 2019 10 11 (9): 3712-3720. Wang Wenxian, Jiang Xiaowen, Zhang Yiping, Song Yong, Song Zheng |
Non-significant efficacy of icotinib plus pleurodesis in epidermal growth factor receptor positive mutant lung cancer patients after malignant pleural effusion drainage compared to icotinib alone. Journal of thoracic disease 2020 May 12 (5): 2499-2506. Xu Yunhua, Fang Wangsheng, Cheng Bingye, Chen Shanshan, Gu Linping, Zhu Li, Pan Yan, Zhou Zh |
FDA Approval Summary: Mobocertinib for Metastatic Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations. Clinical cancer research : an official journal of the American Association for Cancer Research 2022 9 29 (3): 508-512. Duke Elizabeth S, Stapleford Liza, Drezner Nicole, Amatya Anup K, Mishra-Kalyani Pallavi S, Shen Yuan-Li, Maxfield Kimberly, Zirkelbach Jeanne Fourie, Bi Youwei, Liu Jiang, Zhang Xinyuan, Wang Hezhen, Yang Yuching, Zheng Nan, Reece Kelie, Wearne Emily, Glen Jacqueline J, Ojofeitimi Idara, Scepura Barbara, Nair Abhilasha, Bikkavilli Rama Kamesh, Ghosh Soma, Philip Reena, Pazdur Richard, Beaver Julia A, Singh Harpreet, Donoghue Mart |
Association Between EGFR and ALK Mutation Status on Patient-Reported Symptoms After Palliative Radiation for Bone Pain in NSCLC. JTO clinical and research reports 2022 8 3 (8): 100371. Sit Daegan, Bale Michelle, Lapointe Vincent, Olson Robert, Hsu Fr |
Evaluation of Clinical and Genetic Determinants of Treatment OutCome In EGFR Mutation Positive Advanced Lung Adenocarcinoma. Dose-response : a publication of International Hormesis Society 2022 8 20 (3): 15593258221117354. Jokic Vera, Savic-Vujovic Katarina, Spasic Jelena, Bukumiric Zoran, Marinkovic Mladen, Radosavljevic Davorin, Cavic Mile |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: